147 related articles for article (PubMed ID: 38552435)
1. Anti-psoriasis effect of 18β-glycyrrhetinic acid by breaking CCL20/CCR6 axis through its vital active group targeting GUSB/ATF2 signaling.
Wei J; Zhang J; Hu F; Zhang W; Wu Y; Liu B; Lu Y; Li L; Han L; Lu C
Phytomedicine; 2024 Jun; 128():155524. PubMed ID: 38552435
[TBL] [Abstract][Full Text] [Related]
2. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
[TBL] [Abstract][Full Text] [Related]
3. The Protective Effects of 18
Chen H; Liu H; Tang B; Chen Y; Han L; Yu J; Yan Y; Lu C
J Immunol Res; 2020; 2020():1980456. PubMed ID: 32908937
[TBL] [Abstract][Full Text] [Related]
4. 18ß-glycyrrhetinic acid derivative promotes proliferation, migration and aquaporin-3 expression in human dermal fibroblasts.
Hung CF; Hsiao CY; Hsieh WH; Li HJ; Tsai YJ; Lin CN; Chang HH; Wu NL
PLoS One; 2017; 12(8):e0182981. PubMed ID: 28813533
[TBL] [Abstract][Full Text] [Related]
5. The CCL20 and CCR6 axis in psoriasis.
Furue K; Ito T; Tsuji G; Nakahara T; Furue M
Scand J Immunol; 2020 Mar; 91(3):e12846. PubMed ID: 31692008
[TBL] [Abstract][Full Text] [Related]
6. Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3K p110δ and p110γ inhibitions.
Wang CY; Kao TC; Lo WH; Yen GC
J Agric Food Chem; 2011 Jul; 59(14):7726-33. PubMed ID: 21644799
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells.
Xiong H; Xu Y; Tan G; Han Y; Tang Z; Xu W; Zeng F; Guo Q
Cell Physiol Biochem; 2015; 35(4):1335-46. PubMed ID: 25720416
[TBL] [Abstract][Full Text] [Related]
8. Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment.
Kim TG; Byamba D; Wu WH; Lee MG
Exp Dermatol; 2011 Oct; 20(10):855-7. PubMed ID: 21824198
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte transglutaminase 2 promotes CCR6
Shin JW; Kwon MA; Hwang J; Lee SJ; Lee JH; Kim HJ; Lee KB; Lee SJ; Jeong EM; Chung JH; Kim IG
Cell Death Dis; 2020 Apr; 11(4):301. PubMed ID: 32355189
[TBL] [Abstract][Full Text] [Related]
11. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
Front Immunol; 2021; 12():635076. PubMed ID: 34025642
[TBL] [Abstract][Full Text] [Related]
12. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
13. Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.
Getschman AE; Imai Y; Larsen O; Peterson FC; Wu X; Rosenkilde MM; Hwang ST; Volkman BF
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12460-12465. PubMed ID: 29109267
[TBL] [Abstract][Full Text] [Related]
14. Indirubin attenuates IL-17A-induced CCL20 expression and production in keratinocytes through repressing TAK1 signaling pathway.
Zhao J; Xie X; Di T; Liu Y; Qi C; Chen Z; Li P; Wang Y
Int Immunopharmacol; 2021 May; 94():107229. PubMed ID: 33611057
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizic acid and 18beta-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation.
Kao TC; Shyu MH; Yen GC
J Agric Food Chem; 2010 Aug; 58(15):8623-9. PubMed ID: 20681651
[TBL] [Abstract][Full Text] [Related]
16. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis.
Nakayama T; Fujisawa R; Yamada H; Horikawa T; Kawasaki H; Hieshima K; Izawa D; Fujiie S; Tezuka T; Yoshie O
Int Immunol; 2001 Jan; 13(1):95-103. PubMed ID: 11133838
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.
Homey B; Dieu-Nosjean MC; Wiesenborn A; Massacrier C; Pin JJ; Oldham E; Catron D; Buchanan ME; Müller A; deWaal Malefyt R; Deng G; Orozco R; Ruzicka T; Lehmann P; Lebecque S; Caux C; Zlotnik A
J Immunol; 2000 Jun; 164(12):6621-32. PubMed ID: 10843722
[TBL] [Abstract][Full Text] [Related]
18. Cyr61/CCN1 induces CCL20 production by keratinocyte via activating p38 and JNK/AP-1 pathway in psoriasis.
Li H; Li H; Huo R; Wu P; Shen Z; Xu H; Shen B; Li N
J Dermatol Sci; 2017 Oct; 88(1):46-56. PubMed ID: 28602508
[TBL] [Abstract][Full Text] [Related]
19. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizic acid and 18β-glycyrrhetinic acid recover glucocorticoid resistance via PI3K-induced AP1, CRE and NFAT activation.
Kao TC; Wu CH; Yen GC
Phytomedicine; 2013 Feb; 20(3-4):295-302. PubMed ID: 23218403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
